Lipid nanoparticles (LNPs) have gained attention for their role in delivering RNA, notably in successful COVID-19 vaccines by Moderna and Pfizer BioNTech. LNPs are also being utilized for therapeutic treatments, such as small interfering RNA-based drugs for rare diseases like polyneuropathy. One challenging area of development is lung-targeted gene therapy, where LNPs show promise in […]